OBJECTIVE: To evaluate the safety and efficacy of autologous stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA). DESIGN: Retrospective analysis of follow up data on 34 children with JIA who were treated with ASCT in nine different European transplant centres. Rheumatological evaluation employed a modified set of core criteria. Immunological reconstitution and infectious complications were monitored at three month intervals after transplantation. RESULTS: Clinical follow up ranged from 12 to 60 months. Eighteen of the 34 patients (53%) with a follow up of 12 to 60 months achieved complete drug-free remission. Seven of these patients had previously failed treatment with anti-TNF. Six of the 34 patients (18%) showed a partial response (ranging from 30% to 70% improvement) and seven (21%) were resistant to ASCT. Infectious complications were common. There were three cases of transplant related mortality (9%) and two of disease related mortality (6%). CONCLUSIONS: ASCT in severely ill patients with JIA induces a drug-free remission of the disease and a profound increase in general wellbeing in a substantial proportion of patients, but the procedure carries a significant mortality risk. The following adjustments are proposed for future protocols: (1) elimination of total body irradiation from the conditioning regimen; (2) prophylactic administration of antiviral drugs and intravenous immunoglobulins until there is a normal CD4+ T cell count.
OBJECTIVE: To evaluate the safety and efficacy of autologous stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA). DESIGN: Retrospective analysis of follow up data on 34 children with JIA who were treated with ASCT in nine different European transplant centres. Rheumatological evaluation employed a modified set of core criteria. Immunological reconstitution and infectious complications were monitored at three month intervals after transplantation. RESULTS: Clinical follow up ranged from 12 to 60 months. Eighteen of the 34 patients (53%) with a follow up of 12 to 60 months achieved complete drug-free remission. Seven of these patients had previously failed treatment with anti-TNF. Six of the 34 patients (18%) showed a partial response (ranging from 30% to 70% improvement) and seven (21%) were resistant to ASCT. Infectious complications were common. There were three cases of transplant related mortality (9%) and two of disease related mortality (6%). CONCLUSIONS: ASCT in severely ill patients with JIA induces a drug-free remission of the disease and a profound increase in general wellbeing in a substantial proportion of patients, but the procedure carries a significant mortality risk. The following adjustments are proposed for future protocols: (1) elimination of total body irradiation from the conditioning regimen; (2) prophylactic administration of antiviral drugs and intravenous immunoglobulins until there is a normal CD4+ T cell count.
Authors: R Nakagawa; Y Kawano; E Yoshimura; H Suzuya; T Watanabe; S Kanamaru; T Onishi; H Nakayama; R Nakagawa; S Matsuoka; K Yamashita; Y Kuroda Journal: Bone Marrow Transplant Date: 2001-02 Impact factor: 5.483
Authors: D J Lovell; E H Giannini; A Reiff; G D Cawkwell; E D Silverman; J J Nocton; L D Stein; A Gedalia; N T Ilowite; C A Wallace; J Whitmore; B K Finck Journal: N Engl J Med Date: 2000-03-16 Impact factor: 91.245
Authors: Elizabeth Jane Sutton; Tobias D Henning; Sophie Boddington; Stavros Demos; Christian Krug; Reinhardt Meier; John Kornak; Shoujun Zhao; Rick Baehner; Sheida Sharifi; Heike Daldrup-Link Journal: Mol Imaging Date: 2010-10 Impact factor: 4.488
Authors: Narendiran Rajasekaran; Nan Wang; Phi Truong; Cornelia Rinderknecht; Claudia Macaubas; Georg F Beilhack; Judith A Shizuru; Elizabeth D Mellins Journal: Arthritis Rheum Date: 2013-03
Authors: Bin Liu; ShangAn Shu; Thomas P Kenny; Christopher Chang; Patrick S C Leung Journal: Clin Rev Allergy Immunol Date: 2014-10 Impact factor: 8.667
Authors: Elizabeth J Sutton; Sophie E Boddington; Alexander J Nedopil; Tobias D Henning; Stavros G Demos; Rick Baehner; Barbara Sennino; Ying Lu; Heike E Daldrup-Link Journal: Opt Express Date: 2009-12-21 Impact factor: 3.894
Authors: Marion A J van Rossum; Renée M van Soesbergen; Maarten Boers; Aeilko H Zwinderman; Theo J W Fiselier; Marcel J A M Franssen; Rebecca ten Cate; Lisette W A van Suijlekom-Smit; Nico M Wulffraat; Wilma H J van Luijk; Johanna C M Oostveen; Wietse Kuis; Ben A C Dijkmans Journal: Ann Rheum Dis Date: 2007-05-09 Impact factor: 19.103